Cargando…

Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports

BACKGROUND: Sugammadex is a modified gamma-cyclodextrin that acts by selectively encapsulating free amino-steroidal neuromuscular relaxants. Several case reports have been published on the use of sugammadex in patients with neuromuscular disorders that include neuromuscular junction diseases, myopat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gurunathan, Usha, Kunju, Shakeel Meeran, Stanton, Lisa May Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862738/ https://www.ncbi.nlm.nih.gov/pubmed/31744470 http://dx.doi.org/10.1186/s12871-019-0887-3

Ejemplares similares

Usefulness of a visual aid in achieving optimal positioning for spinal anesthesia: a randomized trial
por: Gurunathan, Usha, et al.
Publicado: (2018)

The use of sugammadex in an infant with prolonged neuromuscular blockade - A case report -
por: Kim, Hyunho, et al.
Publicado: (2022)

The successful use of sugammadex and uneventful recovery from general anaesthesia in a patient with myotonic dystrophy
por: Gurunathan, Usha, et al.
Publicado: (2015)

Update on the management of neuromuscular block: focus on sugammadex
por: de Boer, Hans D, et al.
Publicado: (2007)

Sugammadex: A revolutionary drug in neuromuscular pharmacology
por: Nag, Kusha, et al.
Publicado: (2013)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

Unexpected delayed reversal of rocuronium-induced neuromuscular blockade by sugammadex: A case report and review of literature
por: Wang, Hao-Chen, et al.
Publicado: (2022)

Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature
por: Fernandes, Hermann dos Santos, et al.
Publicado: (2019)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
por: Cheong, Soon Ho, et al.
Publicado: (2015)

Sugammadex for reversing neuromuscular blockages after lung surgery: A systematic review and meta-analysis
por: Yang, Jia-Li, et al.
Publicado: (2022)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
por: Carron, Michele, et al.
Publicado: (2017)

The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review
por: Liu, Guangyu, et al.
Publicado: (2017)

Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis
por: Won, Young Ju, et al.
Publicado: (2016)

Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report
por: Kim, Ji Eun, et al.
Publicado: (2017)

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
por: Choi, Shu Chung, et al.
Publicado: (2020)

Sugammadex in systemic mastocytosis: Case report and a systematic review of literature
por: Becerra-Bolaños, A., et al.
Publicado: (2021)

Sugammadex: Anaphylaxis: case report
Publicado: (2021)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
por: Carlos, Ricardo Vieira, et al.
Publicado: (2017)

Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis
por: Staikou, Chryssoula, et al.
Publicado: (2017)

Anesthetic management with a neuromuscular relaxant and sugammadex in a patient with Prader–Willi syndrome: A case report
por: Kim, Kyung Woo, et al.
Publicado: (2020)

Efficacy and safety of sugammadex sodium in reversing rocuronium-induced neuromuscular blockade in children: An updated systematic review and meta-analysis
por: Zhou, Sheng, et al.
Publicado: (2023)

The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex
por: Lee, Hee Jong, et al.
Publicado: (2015)

Effects of adenosine receptor agonist on the rocuroniuminduced neuromuscular block and sugammadex-induced recovery
por: Kim, Yong Beom, et al.
Publicado: (2018)

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
por: Quang, Thuy Luu, et al.
Publicado: (2019)

Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain
por: Martinez-Ubieto, J., et al.
Publicado: (2021)

Use of sugammadex in parotid surgery: a case report
por: Bensghir, Mustapha, et al.
Publicado: (2016)

Use of sugammadex in Rett syndrome: A case report
por: Kupeli, Ilke, et al.
Publicado: (2018)

Successful Neuromuscular Blockade Reversal Using Sugammadex and Neostigmine Failed to Prevent Myasthenic Crisis After Emergency Surgery: A Case Report
por: Haddad, Daniel, et al.
Publicado: (2022)

Postoperative pulmonary complications after sugammadex reversal of neuromuscular blockade: a systematic review and meta-analysis with trial sequential analysis
por: Liu, Hong-Mei, et al.
Publicado: (2023)

Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
por: Kashiwai, Akihiro, et al.
Publicado: (2012)

Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
por: Suzuki, Manzo, et al.
Publicado: (2014)

Sugammadex, a Neuromuscular Blockade Reversal Agent, Causes Neuronal Apoptosis in Primary Cultures
por: Palanca, José M., et al.
Publicado: (2013)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

Sugammadex to Reverse Neuromuscular Blockade in a Child with a Past History of Cardiac Transplantation
por: Miller, Karen, et al.
Publicado: (2017)

Sugammadex to reverse neuromuscular blockade and provide optimal conditions for motor-evoked potential monitoring
por: Trifa, Mehdi, et al.
Publicado: (2017)

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block
por: Koo, Chang-Hoon, et al.
Publicado: (2020)

Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China
por: Ren, Maodong, et al.
Publicado: (2020)

Sugammadex induced bradycardia and hypotension: A case report and literature review
por: Teng, I-Chia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3pje986dh3vhl3e0i6unvnritu